Efinopegdutide

Efinopegdutide is a promising biomedicine designed to target the treatment of obesity and type 2 diabetes. Through its potent agonist activity on the glucagon-like peptide 1 receptor, it promotes weight loss by reducing appetite and increasing feelings of fullness. Additionally, Efinopegdutide improves glycemic control by regulating insulin secretion and glucose metabolism.

Online Inquiry

CAT#R2023
CAS2055640-93-0
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 In 1979, GOLDSTEIN et al. extracted an opioid-active 17 peptide from the pituitary of pigs and named it dynorphi ...

 Obtustatin isolated from the venom of the Vipera lebetina obtusa viper is a highly potent integrin α1β1 inhibito ...

Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be accomplished b ...

 NF-кB activator 1, named Act1, is a 60-kDa (574-aa) polypeptide. Based on its interaction with IKKγ, Act1can be ...

 Corticotropin-releasing factor (CRF) is a 41 amino acid peptide that is an important hormone in the hypothalamic ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.